# Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis

> **NCT01169116** · PHASE2 · WITHDRAWN · sponsor: **Barretos Cancer Hospital**

## Conditions studied

- Cancer
- Metastasis

## Interventions

- **RADIATION:** hypofractionated stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT01169116
- **Lead sponsor:** Barretos Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-07
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled.
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169116, "Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01169116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*